Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 46.69B | 34.73B | 19.61B | 12.21B | 17.75B |
Gross Profit | 35.26B | 25.15B | 10.50B | 470.21M | 5.90B |
EBITDA | 39.91B | 29.12B | 14.77B | 6.44B | 10.55B |
Net Income | 28.04B | 19.95B | 6.09B | -2.59B | 1.05B |
Balance Sheet | |||||
Total Assets | 680.00B | 563.39B | 494.24B | 494.82B | 516.49B |
Cash, Cash Equivalents and Short-Term Investments | 31.96B | 21.96B | 15.55B | 12.76B | 21.21B |
Total Debt | 323.20B | 269.10B | 240.80B | 244.94B | 262.59B |
Total Liabilities | 328.62B | 273.09B | 243.92B | 248.69B | 266.85B |
Stockholders Equity | 351.39B | 290.31B | 250.32B | 246.13B | 249.64B |
Cash Flow | |||||
Free Cash Flow | -72.80B | -33.62B | 10.86B | 11.73B | 7.30B |
Operating Cash Flow | 37.80B | 26.56B | 12.40B | 12.82B | 26.17B |
Investing Cash Flow | -111.26B | -57.52B | -1.57B | -2.75B | -20.69B |
Financing Cash Flow | 83.85B | 45.33B | -7.03B | -19.52B | -8.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥525.31B | 17.64 | 8.51% | 5.58% | 29.48% | 25.62% | |
65 Neutral | £5.45B | 8.77 | 9.49% | 5.11% | 10.05% | -13.15% | |
― | $2.87B | 22.64 | 6.82% | 4.13% | ― | ― | |
78 Outperform | ¥44.47B | 10.32 | 10.41% | 88.08% | 123.31% | ||
76 Outperform | ¥155.83B | 27.83 | 3.45% | 23.80% | 7.98% | ||
― | ¥24.60B | 20.67 | 4.85% | ― | ― | ||
66 Neutral | ¥595.61B | 25.77 | 4.94% | 22.58% | 8.16% |